News Center

February 9, 2024

MIVI Neuroscience™ Presents Primary Endpoint Results from the EvaQ Trial — at the 2024 International Stroke Conference

May 4, 2023

Clinical Trial Enrollment Complete for Study of MIVI Q™ Revascularization System that Treats Acute Ischemic Stroke

June 22, 2022

MIVI Neuroscience grows leadership team

June 7, 2022

MIVI names Dr. Waleed Brinjikji as medical director

May 10, 2022

WLNC Highlights Q Catheter Compatibility in Simulated Robotic Thrombectomy

April 20, 2022

MIVI Announces Multicenter Study Of Q™ Aspiration Catheter In Combined Technique For Thrombus Removal

August 18, 2021

John Wainwright PhD Joins MIVI Neuroscience as Vice President, R&D

July 8, 2021

MIVI Neuroscience Welcomes Tim Hauch as Chief Financial Officer

January 21, 2021

MIVI Neuroscience Secures Series B Funding

December 1, 2020

MIVI Neuroscience Announces First Patient Enrolled in EVAQ Clinical Study for Ischemic Stroke Treatment

June 9, 2020

MIVI Neuroscience Announces FDA IDE Clinical Study Approval For the MIVI Q Aspiration Catheter

March 30, 2020

MIVI Neuroscience Promotes Bob Colloton to CEO and Appoints Robert Stern to Board of Directors